These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22883741)

  • 1. Treatment of nightmares with prazosin: a systematic review.
    Kung S; Espinel Z; Lapid MI
    Mayo Clin Proc; 2012 Sep; 87(9):890-900. PubMed ID: 22883741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares: A Systematic Review.
    Akinsanya A; Marwaha R; Tampi RR
    J Clin Psychopharmacol; 2017 Feb; 37(1):84-88. PubMed ID: 27930498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder.
    George KC; Kebejian L; Ruth LJ; Miller CW; Himelhoch S
    J Trauma Dissociation; 2016; 17(4):494-510. PubMed ID: 26835889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.
    Singh B; Hughes AJ; Mehta G; Erwin PJ; Parsaik AK
    Prim Care Companion CNS Disord; 2016 Jul; 18(4):. PubMed ID: 27828694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
    Taylor HR; Freeman MK; Cates ME
    Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prazosin treatment of nightmares related to posttraumatic stress disorder.
    Dierks MR; Jordan JK; Sheehan AH
    Ann Pharmacother; 2007 Jun; 41(6):1013-7. PubMed ID: 17504838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin for military combat-related PTSD nightmares: a critical review.
    Writer BW; Meyer EG; Schillerstrom JE
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):24-33. PubMed ID: 24515675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prazosin for sleep disturbance and nightmares in post-traumatic stress disorder].
    Versnaeyen L; Debien C; Warembourg F; Ducrocq F; Vaiva G
    Presse Med; 2013 Sep; 42(9 Pt 1):1276-9. PubMed ID: 23453504
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress.
    Seda G; Sanchez-Ortuno MM; Welsh CH; Halbower AC; Edinger JD
    J Clin Sleep Med; 2015 Jan; 11(1):11-22. PubMed ID: 25325592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
    Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
    J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans.
    Breen A; Blankley K; Fine J
    J Am Assoc Nurse Pract; 2017 Feb; 29(2):65-69. PubMed ID: 27977074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis.
    Zhang Y; Ren R; Sanford LD; Yang L; Ni Y; Zhou J; Zhang J; Wing YK; Shi J; Lu L; Tang X
    Sleep Med; 2020 Mar; 67():225-231. PubMed ID: 31972510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of noradrenergic system in PTSD and related sleep disturbances. The use of terazosin in PTSD related nightmares: a case report.
    Salviati M; Pallagrosi M; Valeriani G; Carlone C; Todini L; Biondi M
    Clin Ter; 2013; 164(2):133-7. PubMed ID: 23698207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.
    McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB
    J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F; Raskind MA
    J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
    Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
    Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
    Raskind MA; Peskind ER; Kanter ED; Petrie EC; Radant A; Thompson CE; Dobie DJ; Hoff D; Rein RJ; Straits-Tröster K; Thomas RG; McFall MM
    Am J Psychiatry; 2003 Feb; 160(2):371-3. PubMed ID: 12562588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis.
    Reist C; Streja E; Tang CC; Shapiro B; Mintz J; Hollifield M
    CNS Spectr; 2021 Aug; 26(4):338-344. PubMed ID: 32362287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans.
    Germain A; Richardson R; Moul DE; Mammen O; Haas G; Forman SD; Rode N; Begley A; Nofzinger EA
    J Psychosom Res; 2012 Feb; 72(2):89-96. PubMed ID: 22281448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
    De Berardis D; Marini S; Serroni N; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Tempesta D; Valchera A; Fornaro M; Pompili M; Sepede G; Vellante F; Orsolini L; Martinotti G; Di Giannantonio M
    Curr Drug Targets; 2015; 16(10):1094-106. PubMed ID: 25944011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.